Cargando…
Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells
Adjuvant chemotherapy has become the frequently adopted standard therapeutic approach for non-small cell lung cancer (NSCLC). However, the development of multidrug resistance (MDR) is a major obstacle contributing to the failure of chemotherapy. This study aimed to identify genes associated with MDR...
Autores principales: | Huang, Huaping, Li, Tangying, Chen, Mingjing, Liu, Feng, Wu, Haifeng, Wang, Jie, Chen, Jialiang, Li, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258490/ https://www.ncbi.nlm.nih.gov/pubmed/30505321 http://dx.doi.org/10.1186/s11658-018-0119-8 |
Ejemplares similares
-
Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus
por: Yuan, Fuwen, et al.
Publicado: (2017) -
N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis
por: Huang, Huaping, et al.
Publicado: (2019) -
Pten-NOLC1 Fusion Promotes Cancers Involving MET and EGFR Signalings
por: Luo, Jian-Hua, et al.
Publicado: (2020) -
A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma
por: Wu, Chen-Yan, et al.
Publicado: (2021) -
The interaction between NOLC1 and IAV NS1 protein promotes host cell apoptosis and reduces virus replication
por: Zhu, Chunyu, et al.
Publicado: (2017)